{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:11:40Z","timestamp":1789186300845,"version":"build-2803163510"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T00:00:00Z","timestamp":1550707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s10741-019-09776-3","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T07:23:24Z","timestamp":1550733804000},"page":"521-533","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement"],"prefix":"10.1007","volume":"24","author":[{"given":"Angelos G.","family":"Rigopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Abate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Rahman","family":"Torky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Matiakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mammad","family":"Mammadov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Melnyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"de Vecchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Bigalke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Wohlgemuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Mavrogeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9066-5262","authenticated-orcid":false,"given":"Michel","family":"Noutsias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"issue":"4","key":"9776_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/13506129.2016.1257986","volume":"23","author":"JD Sipe","year":"2016","unstructured":"Sipe JD, Benson MD, Buxbaum JN, Ikeda SI, Merlini G, Saraiva MJ, Westermark P (2016) Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines. Amyloid 23(4):209\u2013213","journal-title":"Amyloid"},{"issue":"10","key":"9776_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11886-017-0911-5","volume":"19","author":"AK Mankad","year":"2017","unstructured":"Mankad AK, Shah KB (2017) Transthyretin cardiac amyloidosis. Curr Cardiol Rep 19(10):97","journal-title":"Curr Cardiol Rep"},{"issue":"12","key":"9776_CR3","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1161\/01.CIR.0000090688.49283.67","volume":"108","author":"P Sanders","year":"2003","unstructured":"Sanders P, Morton JB, Davidson NC, Spence SJ, Vohra JK, Sparks PB, Kalman JM (2003) Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation 108(12):1461\u20131468","journal-title":"Circulation"},{"issue":"14","key":"9776_CR4","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.ehj.2004.04.007","volume":"25","author":"O Leone","year":"2004","unstructured":"Leone O, Boriani G, Chiappini B, Pacini D, Cenacchi G, Martin Suarez S, Rapezzi C, Bacchi Reggiani ML, Marinelli G (2004) Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation. Eur Heart J 25(14):1237\u20131241","journal-title":"Eur Heart J"},{"issue":"4","key":"9776_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0002-9149(97)89403-9","volume":"77","author":"SW Dubrey","year":"1996","unstructured":"Dubrey SW, Cha K, Simms RW, Skinner M, Falk RH (1996) Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis. Am J Cardiol 77(4):313\u2013315","journal-title":"Am J Cardiol"},{"issue":"2","key":"9776_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","volume":"2","author":"SF Mohammed","year":"2014","unstructured":"Mohammed SF, Mirzoyev SA, Edwards WD, Dogan A, Grogan DR, Dunlay SM, Roger VL, Gertz MA, Dispenzieri A, Zeldenrust SR, Redfield MM (2014) Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail 2(2):113\u2013122","journal-title":"JACC Heart Fail"},{"issue":"3","key":"9776_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1080\/07853890701842988","volume":"40","author":"M Tanskanen","year":"2008","unstructured":"Tanskanen M, Peuralinna T, Polvikoski T, Notkola IL, Sulkava R, Hardy J, Singleton A, Kiuru-Enari S, Paetau A, Tienari PJ, Myllykangas L (2008) Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med 40(3):232\u2013239","journal-title":"Ann Med"},{"issue":"14","key":"9776_CR8","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","volume":"135","author":"MS Maurer","year":"2017","unstructured":"Maurer MS, Elliott P, Comenzo R, Semigran M, Rapezzi C (2017) Addressing common questions encountered in the diagnosis and Management of Cardiac Amyloidosis. Circulation 135(14):1357\u20131377","journal-title":"Circulation"},{"issue":"4","key":"9776_CR9","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/0002-9343(83)90443-6","volume":"75","author":"GG Cornwell III","year":"1983","unstructured":"Cornwell GG III, Murdoch WL, Kyle RA, Westermark P, Pitkanen P (1983) Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 75(4):618\u2013623","journal-title":"Am J Med"},{"issue":"Suppl 4","key":"9776_CR10","doi-asserted-by":"publisher","first-page":"16427","DOI":"10.1073\/pnas.202495199","volume":"99","author":"P Hammarstrom","year":"2002","unstructured":"Hammarstrom P, Jiang X, Hurshman AR, Powers ET, Kelly JW (2002) Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity. Proc Natl Acad Sci U S A 99(Suppl 4):16427\u201316432","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9776_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10741-014-9462-7","volume":"20","author":"A Castano","year":"2015","unstructured":"Castano A, Drachman BM, Judge D, Maurer MS (2015) Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs. Heart Fail Rev 20(2):163\u2013178","journal-title":"Heart Fail Rev"},{"issue":"21","key":"9776_CR12","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","volume":"66","author":"MA Gertz","year":"2015","unstructured":"Gertz MA, Benson MD, Dyck PJ, Grogan M, Coelho T, Cruz M, Berk JL, Plante-Bordeneuve V, Schmidt HHJ, Merlini G (2015) Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol 66(21):2451\u20132466","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"9776_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ihj.2015.07.022","volume":"67","author":"U Barbero","year":"2015","unstructured":"Barbero U, Destefanis P (2015) An Indian-look right into restrictive cardiomyopathies. Indian Heart J 67(6):512\u2013513","journal-title":"Indian Heart J"},{"key":"9776_CR14","first-page":"2874902","volume":"2017","author":"A Rammos","year":"2017","unstructured":"Rammos A, Meladinis V, Vovas G, Patsouras D (2017) Restrictive cardiomyopathies: the importance of noninvasive cardiac imaging modalities in diagnosis and treatment-a systematic review. Radiol Res Pract 2017:2874902","journal-title":"Radiol Res Pract"},{"issue":"6","key":"9776_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s10741-017-9641-4","volume":"22","author":"JG Westphal","year":"2017","unstructured":"Westphal JG, Rigopoulos AG, Bakogiannis C, Ludwig SE, Mavrogeni S, Bigalke B, Doenst T, Pauschinger M, Tschope C, Schulze PC, Noutsias M (2017) The MOGE(S) classification for cardiomyopathies: current status and future outlook. Heart Fail Rev 22(6):743\u2013752","journal-title":"Heart Fail Rev"},{"issue":"24","key":"9776_CR16","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133(24):2404\u20132412","journal-title":"Circulation"},{"issue":"8","key":"9776_CR17","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","volume":"1","author":"A Castano","year":"2016","unstructured":"Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, Dispenzieri A, Grogan M, Johnson G, Bokhari S, Maurer MS (2016) Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol 1(8):880\u2013889","journal-title":"JAMA Cardiol"},{"issue":"38","key":"9776_CR18","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","volume":"36","author":"E Gonzalez-Lopez","year":"2015","unstructured":"Gonzalez-Lopez E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral FJ, Cobo-Marcos M, Robles C, Bornstein B, Salas C, Lara-Pezzi E, Alonso-Pulpon L, Garcia-Pavia P (2015) Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J 36(38):2585\u20132594","journal-title":"Eur Heart J"},{"issue":"11","key":"9776_CR19","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C, Investigators A-AS (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 379(11):1007\u20131016","journal-title":"N Engl J Med"},{"issue":"38","key":"9776_CR20","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","volume":"38","author":"A Castano","year":"2017","unstructured":"Castano A, Narotsky DL, Hamid N, Khalique OK, Morgenstern R, DeLuca A, Rubin J, Chiuzan C, Nazif T, Vahl T, George I, Kodali S, Leon MB, Hahn R, Bokhari S, Maurer MS (2017) Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J 38(38):2879\u20132887","journal-title":"Eur Heart J"},{"issue":"23","key":"9776_CR21","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/eurheartj\/ehv583","volume":"37","author":"T Damy","year":"2016","unstructured":"Damy T, Costes B, Hagege AA, Donal E, Eicher JC, Slama M, Guellich A, Rappeneau S, Gueffet JP, Logeart D, Plante-Bordeneuve V, Bouvaist H, Huttin O, Mulak G, Dubois-Rande JL, Goossens M, Canoui-Poitrine F, Buxbaum JN (2016) Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness. Eur Heart J 37(23):1826\u20131834","journal-title":"Eur Heart J"},{"issue":"4","key":"9776_CR22","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ahj.2009.08.006","volume":"158","author":"LH Connors","year":"2009","unstructured":"Connors LH, Prokaeva T, Lim A, Theberge R, Falk RH, Doros G, Berg A, Costello CE, O\u2019Hara C, Seldin DC, Skinner M (2009) Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis. Am Heart J 158(4):607\u2013614","journal-title":"Am Heart J"},{"issue":"10","key":"9776_CR23","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","volume":"68","author":"M Grogan","year":"2016","unstructured":"Grogan M, Scott CG, Kyle RA, Zeldenrust SR, Gertz MA, Lin G, Klarich KW, Miller WL, Maleszewski JJ, Dispenzieri A (2016) Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system. J Am Coll Cardiol 68(10):1014\u20131020","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"9776_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10741-015-9480-0","volume":"20","author":"C Rapezzi","year":"2015","unstructured":"Rapezzi C, Lorenzini M, Longhi S, Milandri A, Gagliardi C, Bartolomei I, Salvi F, Maurer MS (2015) Cardiac amyloidosis: the great pretender. Heart Fail Rev 20(2):117\u2013124","journal-title":"Heart Fail Rev"},{"issue":"5","key":"9776_CR25","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/HCO.0000000000000547","volume":"33","author":"J Nativi-Nicolau","year":"2018","unstructured":"Nativi-Nicolau J, Maurer MS (2018) Amyloidosis cardiomyopathy: update in the diagnosis and treatment of the most common types. Curr Opin Cardiol 33(5):571\u2013579","journal-title":"Curr Opin Cardiol"},{"issue":"24","key":"9776_CR26","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","volume":"38","author":"E Gonzalez-Lopez","year":"2017","unstructured":"Gonzalez-Lopez E, Gagliardi C, Dominguez F, Quarta CC, de Haro-Del Moral FJ, Milandri A, Salas C, Cinelli M, Cobo-Marcos M, Lorenzini M, Lara-Pezzi E, Foffi S, Alonso-Pulpon L, Rapezzi C, Garcia-Pavia P (2017) Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths. Eur Heart J 38(24):1895\u20131904","journal-title":"Eur Heart J"},{"issue":"7","key":"9776_CR27","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/eurheartj\/ehs123","volume":"34","author":"C Rapezzi","year":"2013","unstructured":"Rapezzi C, Quarta CC, Obici L, Perfetto F, Longhi S, Salvi F, Biagini E, Lorenzini M, Grigioni F, Leone O, Cappelli F, Palladini G, Rimessi P, Ferlini A, Arpesella G, Pinna AD, Merlini G, Perlini S (2013) Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective. Eur Heart J 34(7):520\u2013528","journal-title":"Eur Heart J"},{"issue":"2","key":"9776_CR28","first-page":"136","volume":"11","author":"G Qian","year":"2014","unstructured":"Qian G, Wu C, Zhang Y, Chen YD, Dong W, Ren YH (2014) Prognostic value of high-sensitivity cardiac troponin T in patients with endomyocardial-biopsy proven cardiac amyloidosis. J Geriatr Cardiol 11(2):136\u2013140","journal-title":"J Geriatr Cardiol"},{"issue":"4","key":"9776_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/13506120903421538","volume":"16","author":"S Lehrke","year":"2009","unstructured":"Lehrke S, Steen H, Kristen AV, Merten C, Lossnitzer D, Dengler TJ, Katus HA, Giannitsis E (2009) Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis. Amyloid 16(4):187\u2013195","journal-title":"Amyloid"},{"issue":"4","key":"9776_CR30","doi-asserted-by":"publisher","first-page":"e0173086","DOI":"10.1371\/journal.pone.0173086","volume":"12","author":"AV Kristen","year":"2017","unstructured":"Kristen AV, Maurer MS, Rapezzi C, Mundayat R, Suhr OB, Damy T, investigators T (2017) Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS). PLoS One 12(4):e0173086","journal-title":"PLoS One"},{"issue":"30","key":"9776_CR31","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","volume":"39","author":"JD Gillmore","year":"2018","unstructured":"Gillmore JD, Damy T, Fontana M, Hutchinson M, Lachmann HJ, Martinez-Naharro A, Quarta CC, Rezk T, Whelan CJ, Gonzalez-Lopez E, Lane T, Gilbertson JA, Rowczenio D, Petrie A, Hawkins PN (2018) A new staging system for cardiac transthyretin amyloidosis. Eur Heart J 39(30):2799\u20132806","journal-title":"Eur Heart J"},{"issue":"2","key":"9776_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3109\/13506129.2010.483118","volume":"17","author":"J Buxbaum","year":"2010","unstructured":"Buxbaum J, Anan I, Suhr O (2010) Serum transthyretin levels in Swedish TTR V30M carriers. Amyloid 17(2):83\u201385","journal-title":"Amyloid"},{"issue":"sup1","key":"9776_CR33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/13506129.2017.1295371","volume":"24","author":"M Arvanitis","year":"2017","unstructured":"Arvanitis M, Simon S, Chan G, Fine D, Beardsley P, LaValley M, Jacobson D, Koch C, Berk JL, Connors LH, Ruberg FL (2017) Retinol binding protein 4 (RBP4) concentration identifies V122I transthyretin cardiac amyloidosis. Amyloid 24(sup1):120\u2013121","journal-title":"Amyloid"},{"issue":"3","key":"9776_CR34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/jamacardio.2016.5864","volume":"2","author":"M Arvanitis","year":"2017","unstructured":"Arvanitis M, Koch CM, Chan GG, Torres-Arancivia C, LaValley MP, Jacobson DR, Berk JL, Connors LH, Ruberg FL (2017) Identification of transthyretin cardiac amyloidosis using serum retinol-binding protein 4 and a clinical prediction model. JAMA Cardiol 2(3):305\u2013313","journal-title":"JAMA Cardiol"},{"issue":"5","key":"9776_CR35","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/ehf2.12308","volume":"5","author":"YY Mints","year":"2018","unstructured":"Mints YY, Doros G, Berk JL, Connors LH, Ruberg FL (2018) Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience. ESC Heart Fail 5(5):772\u2013779","journal-title":"ESC Heart Fail"},{"issue":"3","key":"9776_CR36","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/ehjci\/jeu291","volume":"16","author":"N Cardim","year":"2015","unstructured":"Cardim N, Galderisi M, Edvardsen T, Plein S, Popescu BA, D\u2019Andrea A, Bruder O, Cosyns B, Davin L, Donal E, Freitas A, Habib G, Kitsiou A, Petersen SE, Schroeder S, Lancellotti P, Camici P, Dulgheru R, Hagendorff A, Lombardi M, Muraru D, Sicari R (2015) Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. Eur Heart J Cardiovasc Imaging 16(3):280","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"9776_CR37","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.amjcard.2004.04.026","volume":"94","author":"JW Ha","year":"2004","unstructured":"Ha JW, Ommen SR, Tajik AJ, Barnes ME, Ammash NM, Gertz MA, Seward JB, Oh JK (2004) Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography. Am J Cardiol 94(3):316\u2013319","journal-title":"Am J Cardiol"},{"issue":"21","key":"9776_CR38","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1136\/heartjnl-2012-301924","volume":"98","author":"JN Dungu","year":"2012","unstructured":"Dungu JN, Anderson LJ, Whelan CJ, Hawkins PN (2012) Cardiac transthyretin amyloidosis. Heart 98(21):1546\u20131554","journal-title":"Heart"},{"issue":"4","key":"9776_CR39","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.echo.2013.12.010","volume":"27","author":"R Suresh","year":"2014","unstructured":"Suresh R, Grogan M, Maleszewski JJ, Pellikka PA, Hanna M, Dispenzieri A, Pereira NL (2014) Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy. J Am Soc Echocardiogr 27(4):440\u2013447","journal-title":"J Am Soc Echocardiogr"},{"issue":"21","key":"9776_CR40","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1136\/heartjnl-2014-305710","volume":"100","author":"E Pozo","year":"2014","unstructured":"Pozo E, Kanwar A, Deochand R, Castellano JM, Naib T, Pazos-Lopez P, Osman K, Cham M, Narula J, Fuster V, Sanz J (2014) Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis. Heart 100(21):1688\u20131695","journal-title":"Heart"},{"issue":"2","key":"9776_CR41","doi-asserted-by":"publisher","first-page":"e000364","DOI":"10.1161\/JAHA.111.000364","volume":"1","author":"SM Banypersad","year":"2012","unstructured":"Banypersad SM, Moon JC, Whelan C, Hawkins PN, Wechalekar AD (2012) Updates in cardiac amyloidosis: a review. J Am Heart Assoc 1(2):e000364","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"9776_CR42","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/0735-1097(96)00202-1","volume":"28","author":"C Tei","year":"1996","unstructured":"Tei C, Dujardin KS, Hodge DO, Kyle RA, Tajik AJ, Seward JB (1996) Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol 28(3):658\u2013664","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"9776_CR43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12574-015-0249-1","volume":"13","author":"F Cacciapuoti","year":"2015","unstructured":"Cacciapuoti F (2015) The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis. J Echocardiogr 13(3):84\u201389","journal-title":"J Echocardiogr"},{"issue":"19","key":"9776_CR44","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","volume":"98","author":"D Phelan","year":"2012","unstructured":"Phelan D, Collier P, Thavendiranathan P, Popovic ZB, Hanna M, Plana JC, Marwick TH, Thomas JD (2012) Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 98(19):1442\u20131448","journal-title":"Heart"},{"issue":"18","key":"9776_CR45","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.113.006242","volume":"129","author":"CC Quarta","year":"2014","unstructured":"Quarta CC, Solomon SD, Uraizee I, Kruger J, Longhi S, Ferlito M, Gagliardi C, Milandri A, Rapezzi C, Falk RH (2014) Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. Circulation 129(18):1840\u20131849","journal-title":"Circulation"},{"issue":"10","key":"9776_CR46","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1093\/ehjci\/jex034","volume":"18","author":"G Habib","year":"2017","unstructured":"Habib G, Bucciarelli-Ducci C, ALP C, Cardim N, Charron P, Cosyns B, Dehaene A, Derumeaux G, Donal E, Dweck MR, Edvardsen T, Erba PA, Ernande L, Gaemperli O, Galderisi M, Grapsa J, Jacquier A, Klingel K, Lancellotti P, Neglia D, Pepe A, Perrone-Filardi P, Petersen SE, Plein S, Popescu BA, Reant P, Sade LE, Salaun E, Slart R, Tribouilloy C, Zamorano J, Committee ESD, Indian Academy of E (2017) Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document In collaboration with the \u201cWorking Group on myocardial and pericardial diseases\u201d of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography. Eur Heart J Cardiovasc Imaging 18(10):1090\u20131121","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"9776_CR47","doi-asserted-by":"crossref","unstructured":"Arvidsson S, Henein MY, Wikstrom G, Suhr OB, Lindqvist P (2018) Right ventricular involvement in transthyretin amyloidosis. Amyloid 25:160\u2013166","DOI":"10.1080\/13506129.2018.1493989"},{"issue":"3","key":"9776_CR48","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.amjcard.2008.09.102","volume":"103","author":"JP Sun","year":"2009","unstructured":"Sun JP, Stewart WJ, Yang XS, Donnell RO, Leon AR, Felner JM, Thomas JD, Merlino JD (2009) Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. Am J Cardiol 103(3):411\u2013415","journal-title":"Am J Cardiol"},{"issue":"11","key":"9776_CR49","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.jcmg.2015.11.013","volume":"9","author":"ED Pagourelias","year":"2016","unstructured":"Pagourelias ED, Duchenne J, Mirea O, Vovas G, Van Cleemput J, Delforge M, Kuznetsova T, Bogaert J, Voigt JU (2016) The relation of ejection fraction and global longitudinal strain in amyloidosis: implications for differential diagnosis. JACC Cardiovasc Imaging 9(11):1358\u20131359","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"9776_CR50","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/j.1540-8175.2012.01680.x","volume":"29","author":"H Baccouche","year":"2012","unstructured":"Baccouche H, Maunz M, Beck T, Gaa E, Banzhaf M, Knayer U, Fogarassy P, Beyer M (2012) Differentiating cardiac amyloidosis and hypertrophic cardiomyopathy by use of three-dimensional speckle tracking echocardiography. Echocardiography 29(6):668\u2013677","journal-title":"Echocardiography"},{"issue":"1","key":"9776_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/13506129.2018.1430027","volume":"25","author":"MY Henein","year":"2018","unstructured":"Henein MY, Suhr OB, Arvidsson S, Pilebro B, Westermark P, Hornsten R, Lindqvist P (2018) Reduced left atrial myocardial deformation irrespective of cavity size: a potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis. Amyloid 25(1):46\u201353","journal-title":"Amyloid"},{"issue":"4","key":"9776_CR52","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/ehjci\/jev342","volume":"17","author":"F Haloui","year":"2016","unstructured":"Haloui F, Salaun E, Maysou L, Dehaene A, Habib G (2016) Cardiac amyloidosis: an unusual cause of low flow-low gradient aortic stenosis with preserved ejection fraction. Eur Heart J Cardiovasc Imaging 17(4):383","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"9776_CR53","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","volume":"6","author":"TD Karamitsos","year":"2013","unstructured":"Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, Whelan CJ, Myerson SG, Robson MD, Hawkins PN, Neubauer S, Moon JC (2013) Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 6(4):488\u2013497","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"9776_CR54","doi-asserted-by":"publisher","first-page":"W394","DOI":"10.2214\/AJR.09.3721","volume":"195","author":"G Bella Di","year":"2010","unstructured":"Di Bella G, Minutoli F, Mazzeo A, Vita G, Oreto G, Carerj S, Anfuso C, Russo M, Gaeta M (2010) MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy. AJR Am J Roentgenol 195(6):W394\u2013W399","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"9776_CR55","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12968-017-0376-0","volume":"19","author":"LK Williams","year":"2017","unstructured":"Williams LK, Forero JF, Popovic ZB, Phelan D, Delgado D, Rakowski H, Wintersperger BJ, Thavendiranathan P (2017) Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics. J Cardiovasc Magn Reson 19(1):61","journal-title":"J Cardiovasc Magn Reson"},{"issue":"2","key":"9776_CR56","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cardfail.2017.08.445","volume":"24","author":"E Pozo","year":"2018","unstructured":"Pozo E, Castellano JM, Kanwar A, Deochand R, Castillo-Martin M, Pazos-Lopez P, Gonzalez-Lengua C, Osman K, Cham M, Cordon-Cardo C, Narula J, Fuster V, Sanz J (2018) Myocardial amyloid quantification with look-locker magnetic resonance sequence in cardiac amyloidosis. Diagnostic accuracy in clinical practice and histological validation. J Card Fail 24(2):78\u201386","journal-title":"J Card Fail"},{"issue":"2","key":"9776_CR57","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","volume":"7","author":"M Fontana","year":"2014","unstructured":"Fontana M, Banypersad SM, Treibel TA, Maestrini V, Sado DM, White SK, Pica S, Castelletti S, Piechnik SK, Robson MD, Gilbertson JA, Rowczenio D, Hutt DF, Lachmann HJ, Wechalekar AD, Whelan CJ, Gillmore JD, Hawkins PN, Moon JC (2014) Native T1 mapping in transthyretin amyloidosis. JACC Cardiovasc Imaging 7(2):157\u2013165","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"9776_CR58","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","volume":"4","author":"C Rapezzi","year":"2011","unstructured":"Rapezzi C, Quarta CC, Guidalotti PL, Pettinato C, Fanti S, Leone O, Ferlini A, Longhi S, Lorenzini M, Reggiani LB, Gagliardi C, Gallo P, Villani C, Salvi F (2011) Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging 4(6):659\u2013670","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"9776_CR59","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10741-014-9463-6","volume":"20","author":"W Noordzij","year":"2015","unstructured":"Noordzij W, Glaudemans AW, Longhi S, Slart RH, Lorenzini M, Hazenberg BP, Rapezzi C (2015) Nuclear imaging for cardiac amyloidosis. Heart Fail Rev 20(2):145\u2013154","journal-title":"Heart Fail Rev"},{"issue":"1","key":"9776_CR60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/13506129.2013.871250","volume":"21","author":"AW Glaudemans","year":"2014","unstructured":"Glaudemans AW, van Rheenen RW, van den Berg MP, Noordzij W, Koole M, Blokzijl H, Dierckx RA, Slart RH, Hazenberg BP (2014) Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis. Amyloid 21(1):35\u201344","journal-title":"Amyloid"},{"issue":"5","key":"9776_CR61","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s12350-017-0799-x","volume":"25","author":"R Morgenstern","year":"2018","unstructured":"Morgenstern R, Yeh R, Castano A, Maurer MS, Bokhari S (2018) (18)Fluorine sodium fluoride positron emission tomography, a potential biomarker of transthyretin cardiac amyloidosis. J Nucl Cardiol 25(5):1559\u20131567","journal-title":"J Nucl Cardiol"},{"issue":"3","key":"9776_CR62","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s00259-017-3814-1","volume":"45","author":"N Ezawa","year":"2018","unstructured":"Ezawa N, Katoh N, Oguchi K, Yoshinaga T, Yazaki M, Sekijima Y (2018) Visualization of multiple organ amyloid involvement in systemic amyloidosis using (11)C-PiB PET imaging. Eur J Nucl Med Mol Imaging 45(3):452\u2013461","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"9776_CR63","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1067\/mhj.2002.123115","volume":"144","author":"M Hongo","year":"2002","unstructured":"Hongo M, Urushibata K, Kai R, Takahashi W, Koizumi T, Uchikawa S, Imamura H, Kinoshita O, Owa M, Fujii T (2002) Iodine-123 metaiodobenzylguanidine scintigraphic analysis of myocardial sympathetic innervation in patients with AL (primary) amyloidosis. Am Heart J 144(1):122\u2013129","journal-title":"Am Heart J"},{"issue":"10","key":"9776_CR64","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s00259-012-2187-8","volume":"39","author":"W Noordzij","year":"2012","unstructured":"Noordzij W, Glaudemans AW, van Rheenen RW, Hazenberg BP, Tio RA, Dierckx RA, Slart RH (2012) (123)I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis. Eur J Nucl Med Mol Imaging 39(10):1609\u20131617","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"9776_CR65","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/ana.24914","volume":"81","author":"Y Misumi","year":"2017","unstructured":"Misumi Y, Ueda M, Yamashita T, Masuda T, Kinoshita Y, Tasaki M, Nagase T, Ando Y (2017) Novel screening for transthyretin amyloidosis by using fat ultrasonography. Ann Neurol 81(4):604\u2013608","journal-title":"Ann Neurol"},{"issue":"6","key":"9776_CR66","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00392-017-1092-3","volume":"106","author":"K Dahlem","year":"2017","unstructured":"Dahlem K, Michels G, Kobe C, Bunck AC, Ten Freyhaus H, Pfister R (2017) Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging. Clin Res Cardiol 106(6):471\u2013473","journal-title":"Clin Res Cardiol"},{"issue":"10","key":"9776_CR67","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.amjcard.2014.02.030","volume":"113","author":"NM Fine","year":"2014","unstructured":"Fine NM, Arruda-Olson AM, Dispenzieri A, Zeldenrust SR, Gertz MA, Kyle RA, Swiecicki PL, Scott CG, Grogan M (2014) Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis. Am J Cardiol 113(10):1723\u20131727","journal-title":"Am J Cardiol"},{"issue":"10","key":"9776_CR68","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","volume":"126","author":"FL Ruberg","year":"2012","unstructured":"Ruberg FL, Berk JL (2012) Transthyretin (TTR) cardiac amyloidosis. Circulation 126(10):1286\u20131300","journal-title":"Circulation"},{"issue":"2","key":"9776_CR69","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","volume":"68","author":"MS Maurer","year":"2016","unstructured":"Maurer MS, Hanna M, Grogan M, Dispenzieri A, Witteles R, Drachman B, Judge DP, Lenihan DJ, Gottlieb SS, Shah SJ, Steidley DE, Ventura H, Murali S, Silver MA, Jacoby D, Fedson S, Hummel SL, Kristen AV, Damy T, Plante-Bordeneuve V, Coelho T, Mundayat R, Suhr OB, Waddington Cruz M, Rapezzi C, Investigators T (2016) Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey). J Am Coll Cardiol 68(2):161\u2013172","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"9776_CR70","doi-asserted-by":"publisher","first-page":"e000289","DOI":"10.1136\/openhrt-2015-000289","volume":"3","author":"T Damy","year":"2016","unstructured":"Damy T, Maurer MS, Rapezzi C, Plante-Bordeneuve V, Karayal ON, Mundayat R, Suhr OB, Kristen AV (2016) Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy. Open Heart 3(1):e000289","journal-title":"Open Heart"},{"issue":"13","key":"9776_CR71","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1056\/NEJM199709253371306","volume":"337","author":"RH Falk","year":"1997","unstructured":"Falk RH, Comenzo RL, Skinner M (1997) The systemic amyloidoses. N Engl J Med 337(13):898\u2013909","journal-title":"N Engl J Med"},{"issue":"6","key":"9776_CR72","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1161\/01.CIR.63.6.1285","volume":"63","author":"A Rubinow","year":"1981","unstructured":"Rubinow A, Skinner M, Cohen AS (1981) Digoxin sensitivity in amyloid cardiomyopathy. Circulation 63(6):1285\u20131288","journal-title":"Circulation"},{"key":"9776_CR73","doi-asserted-by":"crossref","unstructured":"Badar T, D\u2019Souza A, Hari P. Recent advances in understanding and treating immunoglobulin light chain amyloidosis. F1000Res 2018; 7(F1000 Faculty Rev):1348","DOI":"10.12688\/f1000research.15353.1"},{"issue":"2","key":"9776_CR74","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/01.CIR.86.2.431","volume":"86","author":"MA Konstam","year":"1992","unstructured":"Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D et al (1992) Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Circulation 86(2):431\u2013438","journal-title":"Circulation"},{"issue":"7","key":"9776_CR75","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/S0735-1097(00)01006-8","volume":"36","author":"BA Groenning","year":"2000","unstructured":"Groenning BA, Nilsson JC, Sondergaard L, Fritz-Hansen T, Larsson HB, Hildebrandt PR (2000) Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J Am Coll Cardiol 36(7):2072\u20132080","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"9776_CR76","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1161\/CIRCULATIONAHA.110.955039","volume":"122","author":"SD Solomon","year":"2010","unstructured":"Solomon SD, Foster E, Bourgoun M, Shah A, Viloria E, Brown MW, Hall WJ, Pfeffer MA, Moss AJ, Investigators M-C (2010) Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy. Circulation 122(10):985\u2013992","journal-title":"Circulation"},{"issue":"1","key":"9776_CR77","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams D, Gonzalez-Duarte A, O\u2019Riordan WD, Yang CC, Ueda M, Kristen AV, Tournev I, Schmidt HH, Coelho T, Berk JL, Lin KP, Vita G, Attarian S, Plante-Bordeneuve V, Mezei MM, Campistol JM, Buades J, Brannagan TH III, Kim BJ, Oh J, Parman Y, Sekijima Y, Hawkins PN, Solomon SD, Polydefkis M, Dyck PJ, Gandhi PJ, Goyal S, Chen J, Strahs AL, Nochur SV, Sweetser MT, Garg PP, Vaishnaw AK, Gollob JA, Suhr OB (2018) Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med 379(1):11\u201321","journal-title":"N Engl J Med"},{"issue":"10","key":"9776_CR78","first-page":"570","volume":"14","author":"H Wood","year":"2018","unstructured":"Wood H (2018) FDA approves patisiran to treat hereditary transthyretin amyloidosis. Nat Rev Neurol 14(10):570","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"9776_CR79","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1716793","volume":"379","author":"MD Benson","year":"2018","unstructured":"Benson MD, Waddington-Cruz M, Berk JL, Polydefkis M, Dyck PJ, Wang AK, Plante-Bordeneuve V, Barroso FA, Merlini G, Obici L, Scheinberg M, Brannagan TH III, Litchy WJ, Whelan C, Drachman BM, Adams D, Heitner SB, Conceicao I, Schmidt HH, Vita G, Campistol JM, Gamez J, Gorevic PD, Gane E, Shah AM, Solomon SD, Monia BP, Hughes SG, Kwoh TJ, BW ME, Jung SW, Baker BF, Ackermann EJ, Gertz MA, Coelho T (2018) Inotersen treatment for patients with hereditary transthyretin amyloidosis. N Engl J Med 379(1):22\u201331","journal-title":"N Engl J Med"},{"issue":"13","key":"9776_CR80","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s40265-018-0968-5","volume":"78","author":"SJ Keam","year":"2018","unstructured":"Keam SJ (2018) Inotersen: first global approval. Drugs 78(13):1371\u20131376","journal-title":"Drugs"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-019-09776-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09776-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09776-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T08:34:53Z","timestamp":1606552493000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-019-09776-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,21]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["9776"],"URL":"https:\/\/doi.org\/10.1007\/s10741-019-09776-3","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,21]]},"assertion":[{"value":"21 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MN has received grants by the Deutsche Forschungsgemeinschaft through the Sonderforschungsbereich Transregio 19 \u201cInflammatory Cardiomyopathy\u201d (SFB TR19) to MN (TP B2) and to CT (TP B5); and by the University Hospital Giessen and Marburg Foundation Grant \u201cT cell functionality\u201d (UKGM 10\/2009). MN has been consultant to the IKDT (Institute for Cardiac Diagnosis and Therapy GmbH, Berlin) 2004\u20132008, and has received honoraria for presentations and\/or participated in advisory boards from AstraZeneca, Bayer, Fresenius, Miltenyi Biotech, Novartis, Pfizer, and Zoll. AR has received honoraria for presentations from AstraZeneca. MA has received honoraria for presentations from AstraZeneca.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}